CJC-1295 / Ipamorelin
A growth hormone-releasing peptide stack widely used at SSK Longevity in Newport Beach, California, for recovery, body composition, sleep quality, and longevity layering.
The Foundational Growth Peptide Stack
CJC-1295 and Ipamorelin are two complementary peptides that work together to stimulate the body's own growth hormone release in a pulsatile, physiologic pattern. CJC-1295 is a GHRH (growth hormone-releasing hormone) analog. Ipamorelin is a selective GHRP (growth hormone-releasing peptide) that stimulates release without affecting cortisol or prolactin.
This stack is one of the most widely used peptide protocols at SSK Longevity in Newport Beach, prescribed by Dr. Sean Kelishadi, MD FACS and compounded under Sherry Kelishadi, Pharm.D.'s direct pharmacy oversight for Orange County patients.
Why CJC and Ipamorelin Are Stacked Together
The CJC-1295 / Ipamorelin combination creates a synergistic, pulsatile release of growth hormone — closer to natural physiology than either peptide alone. The two compounds activate different but complementary signaling pathways.
GHRH Pathway (CJC-1295)
CJC-1295 acts as a GHRH analog, increasing the amplitude and duration of natural growth hormone pulses through pituitary stimulation.
GHRP Pathway (Ipamorelin)
Ipamorelin selectively stimulates the ghrelin receptor to release growth hormone without raising cortisol, prolactin, or hunger — its key clinical advantage over older GHRPs.
Pulsatile Synergy
Combined, the two peptides produce stronger, more physiologic growth hormone release patterns than either compound alone — closer to the body's own circadian rhythm.
CJC-1295 / Ipamorelin, Compounded for Your Cycle
Every CJC-1295 / Ipamorelin protocol at SSK Longevity Newport Beach is compounded under Sherry Kelishadi, Pharm.D.'s direct review. Dose ratios, injection timing, and complementary peptide layering are evaluated individually for each patient.
Newport Beach, Costa Mesa, Irvine, and Orange County patients receive a CJC/Ipamorelin protocol calibrated to their physiology, training schedule, and longevity goals.
Individual results are not guaranteed and may vary from person to person.
- Personalized lab review and metabolic assessment
- Compounded under Pharm.D. supervision in Newport Beach
- Individualized dose protocols tailored to your physiology
- Drug interaction review before anything is dispensed
- Direct physician access throughout treatment
- Coordinated care with complementary protocols when appropriate
Peptides Layered With CJC-1295 / Ipamorelin
Patients on CJC-1295 / Ipamorelin in Newport Beach often layer or transition to these complementary peptide protocols for cellular health, recovery, and longevity depth.
Peptide Therapy Stacked With Growth Hormone Secretagogues
CJC-1295 / Ipamorelin is rarely the whole protocol. SSK Longevity Newport Beach patients commonly layer it with weight management, recovery, or hormonal protocols. Sherry Kelishadi, Pharm.D. coordinates every combined protocol individually before dispensing.
Tesamorelin / Ipamorelin
GHRH peer (Tesamorelin) stacked with Ipamorelin for patients seeking a different growth hormone release profile, often with body composition emphasis.
Learn More →MOTS-c
Mitochondrial-derived peptide layered with CJC/Ipamorelin for cellular energy, metabolic regulation, and longevity depth.
Learn More →Epithalon
Telomere-supportive peptide commonly cycled alongside CJC/Ipamorelin in longevity protocols at SSK Longevity.
Learn More →CJC-1295 / Ipamorelin Benefits at SSK Longevity in Newport Beach, CA
The CJC-1295 / Ipamorelin growth hormone secretagogue stack at SSK Longevity in Newport Beach delivers reliable improvements in sleep quality, recovery, lean mass preservation, and longevity-relevant outcomes. One of our most prescribed peptide protocols, this stack is compounded under Pharm.D. oversight for patients across Newport Beach, Costa Mesa, Irvine, Laguna Beach, Huntington Beach, Corona del Mar, and Orange County. Below are the clinical and quality-of-life outcomes Newport Beach CJC-1295 / Ipamorelin patients consistently report.
Improved Recovery
Patients commonly report faster recovery from training, reduced soreness, and improved sleep depth — driven by improved nighttime growth hormone release.
Body Composition Support
Sustained physiologic growth hormone release supports lean mass preservation and fat metabolism during weight loss or training cycles.
Deeper Sleep Quality
Patients consistently report deeper, more restorative sleep — reflecting the natural growth hormone surge that occurs during slow-wave sleep.
Skin Quality & Collagen
Growth hormone supports collagen synthesis and skin quality, complementary to aesthetic protocols at SSK.
Stamina & Energy
Patients describe steadier energy and improved exercise tolerance over the course of a 3-6 month protocol cycle.
Cellular Recovery & Repair
Improved tissue turnover supports recovery from injury, training, and overall longevity-focused goals.
Is The CJC-1295 / Ipamorelin Stack Right For You?
CJC-1295 / Ipamorelin at SSK Longevity Newport Beach is appropriate for adults seeking medically supervised peptide therapy with physician oversight, lab-driven protocol design, and Pharm.D.-supervised compounding. Patients pursuing this protocol typically fit one or more of the profiles below.
Conditions Treated Alongside CJC-1295 / Ipamorelin in Newport Beach
How CJC-1295 / Ipamorelin Cycles Are Built at SSK Longevity
Comprehensive Consultation
Lab review, medical history, and goals discussion with the SSK Longevity team in Newport Beach.
Personalized Protocol
CJC-1295 / Ipamorelin dose ratios, injection timing, and protocol length calibrated to your physiology and goals.
Pharmacist Compounding
Sherry Kelishadi, Pharm.D. oversees every compounded CJC/Ipamorelin vial dispensed by SSK Longevity.
Ongoing Clinical Oversight
Scheduled follow-ups, lab rechecks, and dose adjustments calibrated to your response over time.
CJC-1295 / Ipamorelin Safety, IGF-1 Monitoring, and Cycling
CJC-1295 / Ipamorelin therapy under proper medical supervision has a well-characterized safety profile, but real considerations deserve direct discussion before any Newport Beach patient begins a protocol.
-
—
Mild injection-site reactions Localized redness, irritation, or discomfort at the injection site are most common. Typically self-limited and improve with rotation of injection sites.
-
—
IGF-1 elevation requires monitoring Both peptides elevate IGF-1 levels. Pre-protocol baseline and follow-up IGF-1 testing ensure levels stay within physiologically appropriate ranges.
-
—
Contraindicated in active malignancy Growth hormone elevation is generally avoided in patients with active or recent malignancy. Cancer history is screened during initial evaluation.
-
—
Glucose monitoring during long cycles Sustained GH elevation can affect insulin sensitivity. Glucose and HbA1c are monitored, particularly in patients with metabolic risk factors.
-
—
Cycling is typical, not continuous use Most protocols cycle 3-6 months on, followed by an off period. Continuous long-term use is reserved for specific clinical situations under careful monitoring.
-
—
Not appropriate during pregnancy or breastfeeding Growth hormone secretagogues are not used during pregnancy or breastfeeding. Adequate planning is required for patients of reproductive age.
What patients actually say.
"My recovery from training is night and day. The team at SSK got my dosing right and my sleep has never been better."
"I started CJC/Ipamorelin alongside my Tirzepatide protocol to protect lean mass. Sherry walked me through the layering carefully."
"What stood out was the lab-driven approach. They watched my IGF-1 and adjusted my protocol over time. Felt like real medicine, not a peptide refill."
From Our Founders
CJC-1295 / Ipamorelin is one of the most reliably useful peptide stacks we prescribe at SSK Longevity. Pulsatile growth hormone release matters — and the synergy between these two peptides creates a release pattern much closer to natural physiology than older protocols.
The dose ratio between CJC-1295 and Ipamorelin matters enormously, and patients deserve compounded medications calibrated to their specific physiology. Every vial we dispense at SSK Longevity reflects that level of pharmacy attention.
Why Newport Beach Trusts SSK Longevity For Growth Peptide Therapy
CJC-1295 / Ipamorelin FAQ for Newport Beach & Orange County
Is CJC-1295 / Ipamorelin the same as HGH?
No. CJC-1295 / Ipamorelin stimulates the body's own pituitary release of growth hormone in a pulsatile, physiologic pattern. It does not introduce exogenous HGH directly into the bloodstream.
Is this stack FDA-approved?
No. CJC-1295 and Ipamorelin are not FDA-approved for the indications described on this page. They are prescribed off-label under physician supervision and compounded under physician oversight.
How long is a typical protocol?
Most patients commit to a 3-6 month protocol cycle. Length is individualized based on goals, response, and lab markers.
How is CJC-1295 / Ipamorelin layered with weight loss peptides?
Many SSK Longevity patients combine CJC/Ipamorelin with Semaglutide or Tirzepatide to preserve lean mass during weight loss. Layering is always reviewed by Sherry Kelishadi, Pharm.D. for safety and clinical fit.
What labs are monitored during treatment?
IGF-1 is the primary marker monitored during longer protocol cycles. Comprehensive metabolic and hormone panels may be checked periodically depending on your individualized protocol.
How is it injected?
CJC-1295 / Ipamorelin is administered as a daily subcutaneous injection, typically before bed to align with the body's natural growth hormone release cycle.
What are the most common side effects?
Most patients tolerate the protocol well. Possible side effects include injection-site irritation, mild flushing, and occasional water retention during early cycles.
Where is SSK Longevity located?
SSK Longevity is in Newport Beach, California, at 500 Superior Avenue, Suite 340 — serving patients across Orange County including Costa Mesa, Irvine, Huntington Beach, and Laguna Beach.
Treatments Stacked With Growth Peptides at SSK Longevity
CJC-1295 / Ipamorelin is not FDA-approved for the indications described on this page. It is prescribed off-label under physician supervision and compounded under physician oversight. The information on this page is for educational purposes only and does not constitute medical advice. Peptide therapy requires physician evaluation, comprehensive laboratory testing, and ongoing clinical oversight. Compounded peptide therapy is generally an out-of-pocket service and is not typically covered by insurance. Payment options and financing are available. Individual results are not guaranteed and may vary from person to person. All treatments are administered under the supervision of a licensed physician.